The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist
about
A research agenda for helminth diseases of humans: intervention for control and eliminationEpidemiology and control of human gastrointestinal parasites in childrenBacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in miceAn extensive comparison of the effect of anthelmintic classes on diverse nematodesEfficacy of cyclooctadepsipeptides and aminophenylamidines against larval, immature and mature adult stages of a parasitologically characterized trichurosis model in miceEfficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminthsDiscovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibilityUsing a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic studyIn silico approach to screen compounds active against parasitic nematodes of major socio-economic importance.In vitro efficacy of cyclooctadepsipepdtides and aminophenylamidines alone and in combination against third-stage larvae and adult worms of Nippostrongylus brasiliensis and first-stage larvae of Trichinella spiralis.The Conqueror Worm: recent advances with cholinergic anthelmintics and techniques excite research for better therapeutic drugs.Angiostrongylus cantonensis: tegumental and hypodermic alterations of the fourth-stage larvae following administration of tribendimidine in vivo and in vitro.Ion channels and drug transporters as targets for anthelmintics.Advancing Sino-Indian cooperation to combat tropical diseases.Tribendimidine: mode of action and nAChR subtype selectivity in Ascaris and OesophagostomumAnthelmintics: The best way to predict the future is to create it.Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseasesGlycoconjugates in host-helminth interactionsMicrofluidics-enabled method to identify modes of Caenorhabditis elegans paralysis in four anthelmintics.Ion channels and receptor as targets for the control of parasitic nematodes.Investigation of acetylcholine receptor diversity in a nematode parasite leads to characterization of tribendimidine- and derquantel-sensitive nAChRs.Nitazoxanide: nematicidal mode of action and drug combination studies.Progress and challenges in the discovery of macrofilaricidal drugs.Ca²⁺ channels and praziquantel: a view from the free worldCurrent drug targets for helminthic diseases.In vivo efficacy of PF1022A and nicotinic acetylcholine receptor agonists alone and in combination against Nippostrongylus brasiliensis.Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles.Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique."Manifesto" for advancing the control and elimination of neglected tropical diseases.Comparative effect of mebendazole, albendazole, tribendimidine, and praziquantel in treatment of rats infected with Clonorchis sinensis.The astacin metalloprotease moulting enzyme NAS-36 is required for normal cuticle ecdysis in free-living and parasitic nematodes.A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasitesBacillus thuringiensis Cry5B protein as a new pan-hookworm cure.Caenorhabditis elegans susceptibility to Daldinia cf. concentrica bioactive volatiles is coupled with expression activation of the stress-response transcription factor daf-16, a part of distinct nematicidal action.
P2860
Q21562256-0657B424-B9AC-4BCB-8D68-B9BAB9B28B05Q24601973-2DAA2254-D01C-4A2B-996A-497A9EAC4C41Q28473074-18111083-AEE1-4358-8CCB-6EC2DDD4ACC9Q28534669-F67C81EC-E984-4F88-B0C7-7A1444FB5932Q28539946-A10C9803-ADE5-47F1-A5BD-9EB02BB8ABDAQ28541926-A702C5B8-D576-445D-BF19-D8F6BEFF6FC6Q33778375-0C2B5BCA-C6A7-4313-A661-5C0C6A4925E6Q33817389-6ACE026F-BF92-4759-BA27-CF6B6B029F1CQ34176063-299ABA57-4E59-4271-BD90-803E164BCEE1Q34439708-97337B88-1C65-42F5-9CAD-D8664C5A26E9Q34587731-4AB1370D-36E6-4321-9191-EEECC7314DC7Q34752298-A4015F00-F624-4F89-8C61-2570899E220DQ34782668-4E8C8AC7-0CD3-414D-9335-14E2A6E972B4Q35006505-DAD3F6D2-84F7-4334-959E-FA764837F648Q35101636-5EB90AEF-F72E-4B78-9212-45C5603FDF3EQ35931413-5C6043C5-B1D2-4839-9D9A-7D7A55C932CBQ37123637-65C08D48-29A9-483C-BE8B-77ACBE76236CQ37126736-07DEB130-987D-4199-A52B-DC5A81B380E7Q37337055-FEE682F1-3697-4090-AC7E-8BDCF7DC9B15Q37501925-F032C02F-6E6C-4C42-9E0D-23F58DC203EBQ37533979-FDCF8105-B5D7-4DCE-9B75-A09BDE9AF297Q37678601-087A1FBB-F28F-43D4-8F87-910AF02E1ACFQ37912232-8B6315E2-106C-4B4E-A70D-14BC6F707238Q38067995-CCF59EB0-88DD-4547-927A-982719BA7327Q38093067-8B72E18D-65F2-4571-8AC8-5A2FCC5C6BD4Q39150673-86784530-3A46-4824-BF81-849B165ACB6CQ41252057-D4DEF6C5-0326-488D-996D-B78F97D597DBQ41815282-06DAF458-096C-4A82-9FA5-9ED1541A2D6CQ42770755-1D74737E-1A4D-42DA-B166-08C43DE778F6Q47967382-BE6F9F66-2187-45FE-B33A-60BB8A50BC3CQ48063226-C8C592F1-754D-47C0-94F2-350F5142D498Q49401023-08810135-2019-4502-84A4-AC0070EB9ED2Q54157122-797B0CB6-EF6F-496C-9C0E-0323C9FD39E9Q54208548-257BF5DE-46CA-4399-AC83-571B47DA6529Q55003096-52DD50CC-23D7-4AFB-9116-6C152CD67D3E
P2860
The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@ast
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@en
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@nl
type
label
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@ast
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@en
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@nl
prefLabel
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@ast
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@en
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@nl
P2093
P2860
P1476
The new anthelmintic tribendim ...... acetylcholine receptor agonist
@en
P2093
Raffi V Aroian
Shu-Hua Xiao
P2860
P356
10.1371/JOURNAL.PNTD.0000499
P407
P5008
P577
2009-01-01T00:00:00Z